Danish multinational pharmaceutical company Novo Nordisk is the latest player to have evinced interest in India’s Paras Healthcare as the hospital operator looks for capital to expand its operations and pave the way for the exit of its existing backer, Creador.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
